Speakers
Professor Luigi Camporota
Professor Bronwen Connolly
Paul Mouncey
Dr Chris Remmington
Research
We’re thrilled to introduce brand-new SOA26 content in collaboration with UK Critical Care Research Group (UKCCRG).
Across four compelling sessions on Day 2, leading experts will spotlight landmark recent publications, unpack the underpinning science, and bring the evidence to life by exploring its real-world clinical impact.
This is a must-attend series for anyone passionate about staying at the forefront of critical care research and practice. Featured studies include MARCH, BICARICU-2, Andromeda Shock 2, and iRehab.
MARCH Learning objectives:
Co-chairs: David Sapsford and Paul Mouncey
Luigi Camporota is consultant in critical care and Lead of the Severe Respiratory Failure and ECMO Service at St Thomas’ Hospital. He is a Reader (Associate Professor) in Intensive Care Medicine at King’s College London.
Luigi Camporota is the Chair of the Acute Respiratory Failure Section of the European Society of Intensive Care Medicine (ESICM) and on the Editorial Board of the American Journal of respiratory and Critical Care Medicine (AJRCCM) and Intensive Care Medicine (ICM). His clinical and research interest is His clinical and research interest in Respiratory failure, ARDS, mechanical ventilation, respiratory monitoring, extracorporeal membrane oxygenation (ECMO) and extracorporeal carbon dioxide removal (ECCO2R). He has contributed to over 200 published peer-reviewed papers and > 20 book chapters and edited a book in Intensive Care.
Bronwen Connolly is a critical care physiotherapist, and Senior Lecturer in Critical Care at Queen’s University Belfast. She is the Chief Investigator of the NIHR HTA-funded MARCH trial, investigating the effectiveness of mucoactive drugs in acute respiratory failure, and leads the development of a core outcome set for trials of physical rehabilitation in critical illness. Bronwen is the recipient of three previous NIHR Fellowships, and her research interests focus on acute respiratory and rehabilitation physiotherapy, the recovery, long-term outcome and survivorship of post critical illness patients, and clinical trial methodology around complex rehabilitation interventions. Bronwen sits on the NIHR Critical Care National Specialty Group and the UK Critical Care Research Group.
Paul is Co-Director, and Clinical Trials Unit Director, at the Intensive Care National Audit & Research Centre (ICNARC) . Paul is an epidemiologist with over 20 years’ experience of conducting multicentre randomised clinical trials, initially in Cancer, but at ICNARC focussed in adult and paediatric critical care. Paul is currently the Joint-Chief Investigator for the UK-ROX trial (NIHR130508), which is a highly challenging trial within the critical care setting, using extensive data collected routinely by the national clinical audit for critical care (Case Mix Programme) database.
Paul is the lead for the Development of an adaptive platform trial in paediatric critical care and sits on the REMAP-CAP International Trial Steering Committee. He sits on both the NIHR Critical Care National Specialty Specialty Group, which has responsibility for overseeing delivery of studies on the NIHR portfolio for critical care, and the UK Critical Care Research Group.
Chris is a senior pharmacist with extensive experience in intensive care medicine. He is currently undertaking a doctoral fellowship with National Institute for Health and Care Research (NIHR) focusing on protocolised sedation in extracorporeal membrane oxygenation (ECMO) patients. He is employed by Guy’s and St Thomas’ NHS Foundation Trust providing pharmaceutical care to critically ill patients and is an Honorary Senior Lecturer at King’s College London.
He holds national leadership roles including Deputy Chair of the Pharmacy Professionals Advisory Group for the Intensive Care Society and is Chair of the UK ECMO Pharmacist Group. He is research active and has published several peer reviewed articles on ECMO sedation and pharmacy workforce.